Jinling Pharmaceutical Company Limited (SHE:000919)
China
· Delayed Price · Currency is CNY 7.42
+0.04 (0.54%)
At close: Mar 10, 2026
SHE:000919 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,615 | 4,104 | 4,023 | 3,966 | 3,856 | 3,876 | Upgrade
|
| Market Cap Growth | 11.26% | 2.02% | 1.43% | 2.86% | -0.52% | 5.34% | Upgrade
|
| Enterprise Value | 3,300 | 2,644 | 3,503 | 3,076 | 3,156 | 2,918 | Upgrade
|
| Last Close Price | 7.42 | 6.49 | 7.64 | 7.45 | 7.23 | 7.16 | Upgrade
|
| PE Ratio | 143.13 | 101.56 | 37.88 | 37.67 | 31.96 | 59.50 | Upgrade
|
| Forward PE | - | 20.24 | 20.24 | 20.24 | 20.24 | 20.24 | Upgrade
|
| PS Ratio | 1.47 | 1.25 | 1.26 | 1.49 | 1.37 | 1.55 | Upgrade
|
| PB Ratio | 0.95 | 0.85 | 0.91 | 1.09 | 1.09 | 1.13 | Upgrade
|
| P/TBV Ratio | 1.35 | 1.21 | 1.47 | 1.46 | 1.39 | 1.47 | Upgrade
|
| P/FCF Ratio | 27.34 | - | - | - | 29.83 | 193.24 | Upgrade
|
| P/OCF Ratio | 16.77 | 26.62 | 18.97 | 15.22 | 13.20 | 12.44 | Upgrade
|
| PEG Ratio | - | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | Upgrade
|
| EV/Sales Ratio | 1.05 | 0.81 | 1.10 | 1.15 | 1.12 | 1.17 | Upgrade
|
| EV/EBITDA Ratio | 23.49 | 15.62 | 15.24 | 17.72 | 10.84 | 9.94 | Upgrade
|
| EV/EBIT Ratio | - | 104.48 | 43.33 | 60.28 | 18.65 | 16.80 | Upgrade
|
| EV/FCF Ratio | 19.55 | - | - | - | 24.42 | 145.51 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.04 | 0.01 | 0.00 | 0.01 | - | Upgrade
|
| Debt / EBITDA Ratio | 1.35 | 1.08 | 0.18 | 0.03 | 0.06 | - | Upgrade
|
| Debt / FCF Ratio | 1.13 | - | - | - | 0.13 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.49 | -0.51 | -0.47 | -0.50 | -0.42 | -0.38 | Upgrade
|
| Net Debt / EBITDA Ratio | -17.64 | -14.49 | -9.04 | -10.55 | -5.11 | -4.49 | Upgrade
|
| Net Debt / FCF Ratio | -14.04 | 51.71 | 80.36 | 37.35 | -11.50 | -65.67 | Upgrade
|
| Asset Turnover | 0.55 | 0.57 | 0.64 | 0.59 | 0.64 | 0.59 | Upgrade
|
| Inventory Turnover | 9.82 | 9.52 | 9.45 | 8.64 | 9.46 | 8.64 | Upgrade
|
| Quick Ratio | 3.40 | 3.25 | 2.69 | 2.72 | 2.37 | 2.27 | Upgrade
|
| Current Ratio | 3.69 | 3.52 | 2.98 | 3.04 | 2.67 | 2.56 | Upgrade
|
| Return on Equity (ROE) | 0.15% | 0.39% | 3.20% | 3.18% | 4.39% | 2.73% | Upgrade
|
| Return on Assets (ROA) | -0.07% | 0.27% | 1.01% | 0.71% | 2.42% | 2.57% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.09% | 0.48% | 3.40% | 2.37% | 6.35% | 6.56% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.10% | 0.50% | 1.80% | 1.40% | 4.70% | 5.00% | Upgrade
|
| Earnings Yield | 0.70% | 0.98% | 2.64% | 2.66% | 3.13% | 1.68% | Upgrade
|
| FCF Yield | 3.66% | -1.16% | -0.64% | -1.24% | 3.35% | 0.52% | Upgrade
|
| Dividend Yield | 1.35% | 1.54% | 1.31% | 1.34% | 1.38% | 1.40% | Upgrade
|
| Payout Ratio | 220.46% | 156.50% | 48.17% | 48.60% | 42.00% | 138.60% | Upgrade
|
| Buyback Yield / Dilution | -9.53% | -17.56% | -0.01% | 0.02% | 0.01% | -0.02% | Upgrade
|
| Total Shareholder Return | -8.19% | -16.02% | 1.30% | 1.36% | 1.40% | 1.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.